Avendus’s Healthcare practice leverages deep domain knowledge of pharma industry, healthcare providers and services, significant transaction and operating experience to provide strategic and corporate finance advice to a wide range of clients including growing businesses, large corporate houses and private equity funds. The group’s philosophy on every transaction revolves around senior team attention, hands-on approach and independent advice delivering best-in-class solutions to clients.
Sub-Sectors in Focus
Our mergers and acquisitions (M&A) advisory and private equity (PE) syndication services are recognized as amongst the best in these chosen sub-sectors.
- Pharmaceuticals - generics/specialty generics, specialty pharmaceuticals, API / CDMO / CRO
- Healthcare delivery - hospitals, diagnostics, single specialty
- Medical technology - lifesciences, medical devices, consumables
Led By
Chintan Kothari
Executive Director and Head, Healthcare, Avendus Capital
Chintan Kothari leads the Healthcare vertical for Avendus's investment banking business and is based in Mumbai.
He has an overall 15 years of experience in investment banking where he led healthcare and consumer vertical for Citigroup and prior to that for Rothschild India. Chintan has extensive transaction experience aggregating over USD 10 billion across pharmaceuticals (generics, injectables, branded generics, API and animal health) and healthcare sub-sectors (hospitals, diagnostics and single specialty). This covers a broad spectrum of transactions including both private and public markets. He has advised several large corporates including Pfizer, Sun Pharma, Lupin, Hindustan Unilever, United Spirits, Apollo Hospitals, Fortis, Dr. Lal Pathlabs, Metropolis as well as multiple mid-market family-owned businesses and several global private equity (PE) funds.
Chintan holds an MBA degree from Case Western Reserve University, USA and a Bachelor of Commerce degree from Sydenham College, Mumbai. He is a CFA charter holder.
Transactions
Reports
Quality Assurance 3.0
Traditional software testing has a new avatar - Quality Assurance 3.0! Spurred by a growth in emerging technologies, evolving customer expectations, and rapid digital transformation, the USD 40 billion global Digital QA market is projected to grow to USD 70 billion by 2030. Winners are making huge crossovers to deliver the requirements of new-age customers, enabled by cutting-edge technologies and digital-native talent. Our report provides insights into critical elements which have been shaping the Quality Assurance industry.
Retail Health Insurance - A Large Whitespace
This segment has the potential to become a USD 25 billion market in the next five years. Our report aims to identify the key factors which make Health Insurance a highly attractive segment and delves into how Retail Health is expected to be a key growth driver within the overall insurance landscape.
Agritech: Leading next decade‘s tech-first value creation
We anticipate AgriTech to drive the next wave of technology-led impact by growing at a CAGR of ~50% over the next 5 years, addressing a USD 34 billion market by 2027. Our report aims to table the key drivers leading to the success of AgriTech companies in India and deep dive across the value chain.
The Inevitability of Hyperautomation
The hyperautomation technology market is rapidly expanding at a CAGR of 12% and is set to become a USD 860 billion market opportunity by 2025 as per Gartner. In our report, we uncover what drives adoption of hyperautomation by enterprises and highlight emerging themes in the space.
Retail lending in a post covid world – winners and laggards
Banks, NBFCs, FinTech lenders - Two years of the pandemic transformed the competitive landscape in Retail Lending. In our latest report, keeping this fluid environment in mind, we simplify the intricacies and predict the winning models based on three key components - origination, underwriting and collections.
India Unjunking | A USD 30 billion appetite for health food
India is the fastest growing health food market, expanding at 20% CAGR, which is 3x the global average. It is set to become a USD 30 billion market opportunity by 2026. Uncover what is driving valuation in the sector.